Insulin Pen articles & resources on Made-in-China.com

FDA Approval Were Obtained by Novo Nordisk for Two Prefilled Insulin Pens

Nov 5, 2013

Denmark-based medical device company Novo Nordisk has obtained the US Food and Drug Administration (FDA) approval for its NovoLog (insulin aspart [rDNA origin] injection) FlexTouch and Levemir (insulin detemir [rDNA origin] injection) ...

Tags: Prefilled Insulin Pens, Novo Nordisk

Novo Nordisk Has Obtained an Approval From Health Canada for The Levemir FlexTouch

Oct 22, 2013

Global healthcare company Novo Nordisk has obtained an approval from Health Canada for the Levemir FlexTouch, a new disposable insulin injection pen device for use in insulin-treated patients with type 1 and type 2 diabetes mellitus. Novo ...

Tags: Novo Nordisk, Insulin Pen

Novo Nordisk Has Received Approval From Health Canada for Its Levemir Flextouch

Oct 22, 2013

Novo Nordisk has received approval from Health Canada for its Levemir FlexTouch, a disposable prefilled insulin pen containing Levemir (insulin detemir), designed to treat patients with type 1 and type 2 diabetes. FlexTouch has an easy ...

Tags: Treatment of Diabetes, Insulin Pen

BD Invested $4.5m in a Syringe Production Plant in Ireland

Jul 12, 2013

Becton, Dickinson and Company (BD), a medical device company, has invested $4.5m (€3.5m) in a syringe production plant in Ireland. The company has made the investment on new equipment to boost the production of insulin pen needles, ...

Tags: Syringe Manufacturing, medical device

Introduced pen needle BD medical injection easier for diabetes

Jun 25, 2013

BD Medical, a division of Becton, Dickinson and Company, has launched the BD Ultra-Fine Nano 4mm Pen Needle with EasyFlow Technology in US. Making the procedure fast and easy, EasyFlow Technology helps patients in injecting insulin each ...

Tags: Health, Medicine, Medical's Pen Needle

FDA Has Granted Regulatory Approval to Novo Nordisk Dorinsulin Delivery Device in China

Mar 12, 2013

Tianjin Food and Drug Administration has granted regulatory approval to Novo Nordisk to market its new insulin delivery device in China. The NovoPen 5 device, which has the same benefits as its predecessor NovoPen 4 in terms of the design ...

Tags: Novo Nordisk, Chinese Approval, Insulin Delivery Device

Novo Nordisk Has Received an Approval of The Price From Chuikyo

Feb 19, 2013

Novo Nordisk has received an approval of the price from Japan's Central Social Insurance Medical Council (Chuikyo), the advisory committee to the Minister of Health, Labour and Welfare, and is set to launch Tresiba (insulin degludec) in ...

Tags: diabetes therapy, Medical, Novo Nordisk

Novo Nordisk Anticipates Launching Tresiba, Brand Name of Insulin Degludec

Jan 23, 2013

The European Commission has issued clearance to market Novo Nordisk's diabetes therapies, Tresiba and Ryzodeg, across 27 European Union (EU) states. Novo Nordisk anticipates launching Tresiba, brand name of insulin degludec, in the UK and ...

Tags: Ryzodeg diabetes drugs, injection doses, diabetes therapies

Labour and Welfare Has Cleared Novo Nordisk's Diabetes Therapy, Ryzodeg

Dec 27, 2012

The Japanese Ministry of Health, Labour and Welfare has cleared Novo Nordisk's diabetes therapy, Ryzodeg. Ryzodeg, which has been approved to be administered once or twice daily, is the global brand name for insulin degludec/insulin ...

Tags: Novo Nordisk, diabetes therapy, Japan, Health

Sanofi India Will Commercially Launch The First Indian-Manufactured Re-Usable Insulin Pen

Nov 29, 2012

Sanofi India will commercially launch the first Indian-manufactured re-usable insulin pen, AllStar, in India, in October 2012. Developed especially for patients in emerging markets, AllStar is meant for insulinized patients using Sanofi's ...

Tags: Insulin Pen, emerging markets, Sanofi's insulin portfolio

Insulin Pen

Related Products